Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 652,000 | 965,000 | 1,520,000 | 1,610,000 | 2,190,000 |
Marketable Securities | 16,831,000 | 12,987,000 | 10,432,000 | 12,807,000 | 13,767,000 |
Receivables | 9,342,000 | 10,415,000 | 8,636,000 | 8,626,000 | 8,808,000 |
Inventories | 5,863,000 | 5,942,000 | 5,699,000 | 6,701,000 | 6,733,000 |
Other current assets | 838,000 | 2,028,000 | 1,632,000 | 340,000 | 234,000 |
TOTAL | $36,685,000 | $35,389,000 | $30,677,000 | $33,067,000 | $34,744,000 |
Non-Current Assets | |||||
PPE Net | 17,299,000 | 17,703,000 | 18,156,000 | 17,961,000 | 18,279,000 |
Investments And Advances | 4,420,000 | 5,430,000 | 6,142,000 | 5,962,000 | 6,086,000 |
Intangibles | 57,289,000 | 59,454,000 | 57,856,000 | 57,151,000 | 59,537,000 |
Other Non-Current Assets | 4,268,000 | 4,313,000 | 3,944,000 | 5,917,000 | 5,612,000 |
TOTAL | $83,276,000 | $86,900,000 | $86,098,000 | $86,991,000 | $89,514,000 |
Total Assets | $119,961,000 | $122,289,000 | $116,775,000 | $120,058,000 | $124,258,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 12,204,000 | 10,692,000 | 8,818,000 | 9,396,000 | 8,214,000 |
Accounts payable and accrued liabilities | 2,480,000 | 2,479,000 | 2,587,000 | 1,998,000 | 2,121,000 |
Accrued Expenses | 1,599,000 | 1,636,000 | 1,740,000 | 1,539,000 | 1,420,000 |
Other current liabilities | 5,785,000 | 6,857,000 | 5,850,000 | 5,049,000 | 5,333,000 |
TOTAL | $25,158,000 | $24,637,000 | $23,909,000 | $21,660,000 | $22,157,000 |
Non-Current Liabilities | |||||
Long Term Debt | 6,765,000 | 7,144,000 | 5,755,000 | 6,439,000 | 6,710,000 |
Other Non-Current Liabilities | 8,566,000 | 8,407,000 | 8,722,000 | 8,548,000 | 9,176,000 |
TOTAL | $28,098,000 | $28,604,000 | $27,489,000 | $29,867,000 | $31,819,000 |
Total Liabilities | $53,256,000 | $53,241,000 | $51,398,000 | $51,527,000 | $53,976,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 7,550,776 | 7,630,537 | 7,625,056 | 7,631,523 | 7,786,224 |
Common Shares | 437,000 | 436,000 | 435,000 | 434,000 | 434,000 |
Retained earnings | 32,003,000 | 31,707,000 | 29,382,000 | 31,191,000 | 28,923,000 |
Other shareholders' equity | -1,181,000 | 408,000 | -1,484,000 | -2,831,000 | -2,239,000 |
TOTAL | $66,705,000 | $69,048,000 | $65,377,000 | $68,531,000 | $70,282,000 |
Total Liabilities And Equity | $119,961,000 | $122,289,000 | $116,775,000 | $120,058,000 | $124,258,000 |